Showing results (1-10 of 151) with videos related to
Sort By:
Pageof 16
Hematology/Oncology Clinics of North America|October 11, 2005
Bone and joint disease in sickle cell diseaseChristine Aguilar, Elliott Vichinsky, Lynne NeumayrPediatric Hematology and Oncology|May 24, 2017
Encephaloduroarteriosynangiosis (EDAS) in young patients with cerebrovascular complications of sickle cell disease: Single-institution experienceMichael Winstead, Peter P Sun, Kenneth Martin, et al.Pediatric Blood & Cancer|September 2, 2014
Population based surveillance in sickle cell disease: methods, findings and implications from the California registry and surveillance system in hemoglobinopathies project (RuSH)Susan T Paulukonis, William T Harris, Thomas D Coates, et al.Blood Cells, Molecules & Diseases|November 16, 2012
Combined chelation therapy with deferasirox and deferoxamine in thalassemiaAshutosh Lal, John Porter, Nancy Sweeters, et al.American Journal of Hematology|December 7, 2007
Clinical application of deferasirox: practical patient managementElliott VichinskyHematology. American Society of Hematology. Education Program|December 13, 2012
Emerging 'A' therapies in hemoglobinopathies: agonists, antagonists, antioxidants, and arginineElliott VichinskyHematology. American Society of Hematology. Education Program|November 21, 2007
Hemoglobin e syndromesElliott VichinskyAnnals of the New York Academy of Sciences|August 18, 2010
Complexity of alpha thalassemia: growing health problem with new approaches to screening, diagnosis, and therapyElliott VichinskyCurrent Medical Research and Opinion|October 20, 2015
Non-transfusion-dependent thalassemia and thalassemia intermedia: epidemiology, complications, and managementElliott VichinskyPageof 16